Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Travere Therapeutics Inc stake
total: 670
Viking Global Investors TVTX trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2024 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2025 Q2
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Travere Therapeutics Inc (TVTX) shares. To date, the estimated cost basis is nearly $17.42 for "buy" trades and estimated average "sell" price is $17.92. Viking Global Investors first purchased TVTX in 2024 Q4, initially acquiring about 2.90M shares. Since the initial investment in Travere Therapeutics Inc (TVTX), Viking Global Investors has made 2 more transactions.
When did Ole Andreas Halvorsen sell Travere Therapeutics Inc (TVTX)?
Ole Andreas Halvorsen sold off the entire Travere Therapeutics Inc (TVTX) position in 2025 Q2.
When did Ole Andreas Halvorsen buy Travere Therapeutics Inc (TVTX)?
Ole Andreas Halvorsen first invested in Travere Therapeutics Inc (TVTX) in 2024 Q4 at the reported quarter-end price of $17.42 per share.
What's the cost basis of Viking Global Investors's TVTX stake?
The estimated cost basis for Travere Therapeutics Inc (TVTX) stake is around $17.42 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $17.42
- Weighted AVG sell price:
- $17.92
Ole Andreas Halvorsen's historical trades in Travere Therapeutics Inc
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$17.92
|
|
-100% (-2,601,922)
|
-0.15%
|
|
2025 Q1
|
0.15%
|
2,601,922
|
$17.92
|
$46,626,442
|
-10.34% (-300,003)
|
-0.02%
|
|
2024 Q4
|
0.16%
|
2,901,925
|
$17.42
|
$50,551,534
|
new
|
+0.16%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.